Opdivo is generally considered for patients with advanced or recurrent gynecologic cancers who have not responded to other treatments. Factors that may influence its use include the specific type and stage of cancer, the patient's overall health, and previous treatment history. A thorough evaluation by a gynecologic oncologist is essential to determine if Opdivo is an appropriate treatment option.
